嚢胞性線維症(Cystic Fibrosis)：世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cystic Fibrosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cystic Fibrosis to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cystic Fibrosis to Respiratory Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cystic Fibrosis 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Cystic Fibrosis Therapeutics Clinical Trials 33
Prominent Drugs 34
Latest Clinical Trials News on Cystic Fibrosis 35
Nov 12, 2014: Arcturus Presents mRNA Delivery Data Applicable To CF Treatment 35
Oct 30, 2014: Phase 3 Clinical Trial in Cystic Fibrosis Begins 35
Oct 09, 2014: N8 Respiratory Presents Data Demonstrating Antimicrobial Efficacy of CSA-13 Against Psuedomonas Aeruginosa Biofilm 36
Sep 29, 2014: New data supports RPL554 as a potential novel cystic fibrosis therapy 36
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
Vertex Pharmaceuticals Incorporated 38
Clinical Trial Overview of Vertex Pharmaceuticals Incorporated 38
Novartis AG 41
Clinical Trial Overview of Novartis AG 41
Gilead Sciences, Inc. 43
Clinical Trial Overview of Gilead Sciences, Inc. 43
Actavis plc 45
Clinical Trial Overview of Actavis plc 45
C. H. Boehringer Sohn AG & Co. KG 47
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 47
Merck & Co., Inc. 48
Clinical Trial Overview of Merck & Co., Inc. 48
PTC Therapeutics, Inc. 49
Clinical Trial Overview of PTC Therapeutics, Inc. 49
F. Hoffmann-La Roche Ltd. 50
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 50
Pharmaxis Limited 51
Clinical Trial Overview of Pharmaxis Limited 51
Abbott Laboratories 52
Clinical Trial Overview of Abbott Laboratories 52
Clinical Trial Overview of Top Institutes / Government 53
The Hospital for Sick Children 53
Clinical Trial Overview of The Hospital for Sick Children 53
The National Institute of Diabetes and Digestive and Kidney Diseases 54
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 54
National Center for Research Resources 55
Clinical Trial Overview of National Center for Research Resources 55
University of British Columbia 56
Clinical Trial Overview of University of British Columbia 56
University of Pittsburgh 57
Clinical Trial Overview of University of Pittsburgh 57
University of Alabama at Birmingham 58
Clinical Trial Overview of University of Alabama at Birmingham 58
Emory University 59
Clinical Trial Overview of Emory University 59
Imperial College London 60
Clinical Trial Overview of Imperial College London 60
University of North Carolina 61
Clinical Trial Overview of University of North Carolina 61
University of Texas Southwestern Medical Center at Dallas 62
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 62
Five Key Clinical Profiles 63
Appendix 106
Abbreviations 106
Definitions 106
Research Methodology 107
Secondary Research 107
About GlobalData 108
Contact Us 108
Disclaimer 108
Source 108